Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 2 Trials for Montelukast (DB00471)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01307462Targeted Therapy of Bronchiolitis Obliterans SyndromeTreatment
NCT00656058Montelukast to Treat Bronchiolitis ObliteransTreatment